Search Result "YM150"
Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 3 Year: 2012 Page: 195-208
Author(s): Spyridon Deftereos,Georgios Bouras,Georgios Giannopoulos,Charalambos Kossyvakis,Vasiliki Panagopoulou,Vlasios Pyrgakis,Christodoulos Stefanadis
Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 4 Year: 2017 Page: 338-350
Author(s): Yi-Ping Dang,Yun-Fei Chen,Yi-Qing Li,Lei Zhao
Update on Pharmacologic Approaches to Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer?
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 350-357
Author(s): Oliver Wolfram, Matthias Hammwoehner, Felix Gramley, Andreas Goette
New Anticoagulants: Focus on Venous Thromboembolism
Journal: Current Vascular Pharmacology
Volume: 7 Issue: 3 Year: 2009 Page: 309-329
Author(s): Antonio Gomez-Outes, Ramon Lecumberri, Carmen Pozo, Eduardo Rocha
New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors
Journal: Current Drug Discovery Technologies
Volume: 9 Issue: 2 Year: 2012 Page: 119-128
Author(s): Cecilia Becattini,Alessandra Lignani,Giancarlo Agnelli
Novel Anticoagulants: New Evidence for Emerging Drugs and Their Potential Application in Major Lower Limb Surgery
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 54-60
Author(s): Vassilios S. Nikolaou, Paul J. Harwood, Efthimios J. Karadimas, Hiang Boon Tan, Peter V. Giannoudis
Emerging Anticoagulants
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 20 Year: 2012 Page: 3388-3416
Author(s): B. Kennedy,F. S. Gargoum,L. Kennedy,F. Khan,D. R. Curran,T. M. O’Connor
Novel Direct Factor IIa and Xa Inhibitors: Mechanisms of Action and Preclinical Studies
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 3 Year: 2012 Page: 149-165
Author(s): Spyridon Deftereos,Nikolaos Anatoliotakis,Georgios Giannopoulos,Andreas Kaoukis,Maria Mavri,Vlasios Pyrgakis,Christodoulos Stefanadis
Use of Oral Direct Factor Xa Inhibiting Anticoagulants in Elective Hip and Knee Arthroplasty: A Meta-analysis of Efficacy and Safety Profiles Compared with those of Low-Molecular-Weight Heparins
Journal: Current Vascular Pharmacology
Volume: 11 Issue: 3 Year: 2013 Page: 366-375
Author(s): Mohammed As-Sultany, Joseph Pagkalos, Sara Yeganeh, Cheryl L. Craigs, Nectarios Korres, Robert M. West, Eleftherios Tsiridis
Incidence and Prevention of Thromboembolic Events in One Stage Bilateral Total Hip Arthroplasty: A Systematic Review
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 24-32
Author(s): George C. Babis, Vasileios I. Sakellariou, Elizabeth O. Johnson, Panayotis N. Soucacos